Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases
Condition(s):Primary Myelofibrosis (PMF); Post-Polycythaemia Vera; Essential Thrombocythaemia MyelofibrosisLast Updated:April 24, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Primary Myelofibrosis (PMF); Post-Polycythaemia Vera; Essential Thrombocythaemia MyelofibrosisLast Updated:April 24, 2017Completed
Condition(s):Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase; Primary MyelofibrosisLast Updated:August 20, 2019Withdrawn
Condition(s):Polycythemia Vera; Essential ThrombocythemiaLast Updated:September 21, 2018Completed
Condition(s):Primary Myelofibrosis; Polycythemia Vera; Post-Essential Thrombocythemia MyelofibrosisLast Updated:January 5, 2022Completed
Condition(s):Myelofibrosis Due to and Following Polycythemia VeraLast Updated:September 8, 2023Recruiting
Condition(s):Primary Myelofibrosis (PMF); Post-Polycythemia Vera MF (Post-PV-MF); Post-Essential Thrombocythemia MF (Post-ET-MF)Last Updated:April 28, 2023Recruiting
Condition(s):Primary Myelofibrosis; Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase; Post-Essential Thrombocythemia Related MyelofibrosisLast Updated:March 6, 2015Unknown status
Condition(s):Polycythemia Vera; Essential ThrombocythemiaLast Updated:June 19, 2020Completed
Condition(s):MyelofibrosisLast Updated:March 10, 2014Completed
Condition(s):Thrombocythemia, Essential; Primary MyelofibrosisLast Updated:March 22, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.